Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Yasuda

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuropathology and Experimental Neurology|July 16, 2011
Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson diseaseToru Yasuda, Hideki Hayakawa, Tomoko Nihira, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2012
Accumulation of α-synuclein triggered by presynaptic dysfunctionYasuto Nakata, Toru Yasuda, Masahiro Fukaya, et al.
Biochemical and Biophysical Research Communications|December 1, 2005
Characterization of multimetric variants of ubiquitin carboxyl-terminal hydrolase L1 in water by small-angle neutron scatteringSachio Naito, Hideki Mochizuki, Toru Yasuda, et al.
Molecular Therapy. Methods & Clinical Development|November 17, 2021
Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clonesToru Uchiyama, Sirirat Takahashi, Kazuhiko Nakabayashi, et al.
British Journal of Haematology|September 15, 2025
Differential transcript level of ANKRD26 and clinical phenotype among the ANKRD26 variants in the Japanese registry for congenital thrombocytopeniaAtsushi Sakamoto, Toru Uchiyama, Kazuhiko Nakabayashi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2023
Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGDToru Uchiyama, Toshinao Kawai, Kazuhiko Nakabayashi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuropathology and Experimental Neurology|July 16, 2011
Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson diseaseToru Yasuda, Hideki Hayakawa, Tomoko Nihira, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2012
Accumulation of α-synuclein triggered by presynaptic dysfunctionYasuto Nakata, Toru Yasuda, Masahiro Fukaya, et al.
Biochemical and Biophysical Research Communications|December 1, 2005
Characterization of multimetric variants of ubiquitin carboxyl-terminal hydrolase L1 in water by small-angle neutron scatteringSachio Naito, Hideki Mochizuki, Toru Yasuda, et al.
Molecular Therapy. Methods & Clinical Development|November 17, 2021
Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clonesToru Uchiyama, Sirirat Takahashi, Kazuhiko Nakabayashi, et al.
British Journal of Haematology|September 15, 2025
Differential transcript level of ANKRD26 and clinical phenotype among the ANKRD26 variants in the Japanese registry for congenital thrombocytopeniaAtsushi Sakamoto, Toru Uchiyama, Kazuhiko Nakabayashi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2023
Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGDToru Uchiyama, Toshinao Kawai, Kazuhiko Nakabayashi, et al.
Pageof 4